Regular Delivery Service, let us remember for you!
Cerenia
16mg » Pack of 4
20ml Solution » Bottle
24mg » Pack of 4
160mg » Pack of 4

  • 16mg » Pack of 4 £9.49
  • 20ml Solution » Bottle £109.49
  • 24mg » Pack of 4 £10.49
  • 60mg » Pack of 4 £20.50
  • 160mg » Pack of 4 £28.99

Selection of 5 products from

£9.49 to £109.49

Description

This product is sourced in the United Kingdom and is intended for use in the United Kindgom only.

Cerenia is used to control nausea and vomiting.

  • Cerenia can be used along with other appropriate therapy.
  • Cerenia can be given before car journeys to prevent the symptoms of motion sickness.
  • Cerenia is also used to prevent nausea associated with chemotherapy administration.

Contra-indications, warnings, etc

Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.
The safety of Cerenia has not been established in dogs less than 16 weeks of age and in pregnant or lactating bitches. Use only according to a risk benefit assessment by the responsible veterinary surgeon.
Cerenia should be used in conjunction with other supportive measures if appropriate.
Cerenia should be used with caution in dogs with liver disease.
Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases.


Wash hands after use. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.

Need help or advice? Contact us:

  • Landline: 01582 842096
  • Mon - Fri: 8:30am - 5:00pm
  • Sat: 9:00am - 1:00pm (Collections only)
  • Email: [email protected]

All prices include VAT where applicable.

Medication Datasheets

60mg » Pack of 4

Cerenia Tablets for dogs

Presentation

Each tablet contains 16 mg, 24 mg, 60 mg or 160 mg maropitant as maropitant citrate monohydrate. The tablets also contain Sunset Yellow (E110) as a colourant.

The tablets are pale orange and have a score line on both sides allowing the tablet to be halved. Each tablet is marked with the Pfizer logo on the reverse side. On the obverse side, each half is marked with the letters “MPT” and figures denoting the quantity of maropitant.

Uses

Cerenia tablets are indicated for the following:

Dosage and administration

For oral use in dogs.

For the prevention of nausea induced by chemotherapy and treatment and prevention of vomiting (except motion sickness) in dogs aged 8 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 2 mg maropitant per kg bodyweight, using the number of tablets given in the table below. Tablets are breakable along the score line on the tablet.

To prevent vomiting, tablets should be given more than 1 hour in advance. The duration of the effect is approximately 24 hours and, therefore, tablets can be given the night before administration of an agent that may cause emesis (e.g. chemotherapy).

Cerenia can be used as either tablets or Solution for Injection once daily. Cerenia Solution for Injection may be administered for up to five days and Cerenia Tablets for up to 14 days.

Cerenia tablets are effective in the treatment of vomiting, however in cases of frequent vomiting it is recommended to initiate treatment with Cerenia Solution for Injection.

* Correct dose for dogs of less than 3 kg cannot be accurately achieved.

For prevention of vomiting induced by motion sickness in dogs aged 16 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 8 mg maropitant per kg bodyweight, using the numbers of tablets given in the table below. Tablets are breakable along the score line on the tablet.

Tablets should be administered at least one hour before starting the journey. The anti-emetic effect persists for at least 12 hours, which for convenience may allow administration the night before early morning travel. Treatment may be repeated for a maximum of two consecutive days.

In some individual dogs and when repeating the treatment, lower doses than recommended might be sufficient.

To remove a tablet from the blister the following sequence should be carried out;

Note: No attempt should be made to remove the tablet by pushing it through the blister backing as this will damage both the tablet and blister.

A light meal or snack before dosing is recommended; prolonged fasting before administration should be avoided. Cerenia tablets should not be administered wrapped or encapsulated in food as this may delay dissolution of the tablet and consequently the onset of the effect.

Dogs should be carefully observed following administration to ensure that each tablet is swallowed.

Contra-indications, warnings, etc

Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.

Administering Cerenia on a completely empty stomach may cause the dog to vomit. A light snack before dosing could help prevent this effect.

The safety of Cerenia has not been established in dogs less than 16 weeks of age (for the 8 mg/kg dose: motion sickness) and in dogs less than 8 weeks of age (for the 2 mg/kg dose: vomiting), as well as in pregnant or lactating bitches. Use only according to a risk benefit assessment by the responsible veterinary surgeon.

Cerenia should be used in conjunction with other supportive measures if appropriate.

Cerenia tablets were well tolerated when administered for 15 days at dosages up to 10 mg/kg bodyweight per day. Clinical signs including vomiting on first administration, excess salivation and watery faeces have been observed when the product has been overdosed in excess of 20 mg/kg.

The safety of maropitant during treatment beyond 5 days has not been explored in young dogs with viral enteritis. In case treatment for a longer period than 5 days is required, careful monitoring of potential adverse events should be implemented.

Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease. As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function in addition to any adverse events should be implemented during long term treatment.

Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases. Cerenia should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.

Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.

Cerenia is not a sedative and some motion sick dogs may show nausea-like signs during travel such as salivation and lethargy. These signs are temporary and should resolve when the journey ends.

Incidents of pre-travel vomiting, usually within two hours post-dosing, were commonly reported (more than 1 but less than 10 animals in 100 animals treated) after administration of the 8 mg/kg dose.

User warnings

People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.

Wash hands after use. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Half-tablets should be stored for a maximum of two days after removal from the blister. Half-tablets should be returned to the opened blister and kept within the cardboard outer.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Keep out of the sight and reach of children.

For animal treatment only.

Legal category

Packaging quantities

Cerenia tablets are supplied in blister packs with four tablets per pack.

Further information

Nil.

Marketing Authorisation Number

EU/2/06/062/001-004

24mg » Pack of 4

Cerenia Tablets for dogs

Presentation

Each tablet contains 16 mg, 24 mg, 60 mg or 160 mg maropitant as maropitant citrate monohydrate. The tablets also contain Sunset Yellow (E110) as a colourant.

The tablets are pale orange and have a score line on both sides allowing the tablet to be halved. Each tablet is marked with the Pfizer logo on the reverse side. On the obverse side, each half is marked with the letters “MPT” and figures denoting the quantity of maropitant.

Uses

Cerenia tablets are indicated for the following:

Dosage and administration

For oral use in dogs.

For the prevention of nausea induced by chemotherapy and treatment and prevention of vomiting (except motion sickness) in dogs aged 8 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 2 mg maropitant per kg bodyweight, using the number of tablets given in the table below. Tablets are breakable along the score line on the tablet.

To prevent vomiting, tablets should be given more than 1 hour in advance. The duration of the effect is approximately 24 hours and, therefore, tablets can be given the night before administration of an agent that may cause emesis (e.g. chemotherapy).

Cerenia can be used as either tablets or Solution for Injection once daily. Cerenia Solution for Injection may be administered for up to five days and Cerenia Tablets for up to 14 days.

Cerenia tablets are effective in the treatment of vomiting, however in cases of frequent vomiting it is recommended to initiate treatment with Cerenia Solution for Injection.

* Correct dose for dogs of less than 3 kg cannot be accurately achieved.

For prevention of vomiting induced by motion sickness in dogs aged 16 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 8 mg maropitant per kg bodyweight, using the numbers of tablets given in the table below. Tablets are breakable along the score line on the tablet.

Tablets should be administered at least one hour before starting the journey. The anti-emetic effect persists for at least 12 hours, which for convenience may allow administration the night before early morning travel. Treatment may be repeated for a maximum of two consecutive days.

In some individual dogs and when repeating the treatment, lower doses than recommended might be sufficient.

To remove a tablet from the blister the following sequence should be carried out;

Note: No attempt should be made to remove the tablet by pushing it through the blister backing as this will damage both the tablet and blister.

A light meal or snack before dosing is recommended; prolonged fasting before administration should be avoided. Cerenia tablets should not be administered wrapped or encapsulated in food as this may delay dissolution of the tablet and consequently the onset of the effect.

Dogs should be carefully observed following administration to ensure that each tablet is swallowed.

Contra-indications, warnings, etc

Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.

Administering Cerenia on a completely empty stomach may cause the dog to vomit. A light snack before dosing could help prevent this effect.

The safety of Cerenia has not been established in dogs less than 16 weeks of age (for the 8 mg/kg dose: motion sickness) and in dogs less than 8 weeks of age (for the 2 mg/kg dose: vomiting), as well as in pregnant or lactating bitches. Use only according to a risk benefit assessment by the responsible veterinary surgeon.

Cerenia should be used in conjunction with other supportive measures if appropriate.

Cerenia tablets were well tolerated when administered for 15 days at dosages up to 10 mg/kg bodyweight per day. Clinical signs including vomiting on first administration, excess salivation and watery faeces have been observed when the product has been overdosed in excess of 20 mg/kg.

The safety of maropitant during treatment beyond 5 days has not been explored in young dogs with viral enteritis. In case treatment for a longer period than 5 days is required, careful monitoring of potential adverse events should be implemented.

Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease. As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function in addition to any adverse events should be implemented during long term treatment.

Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases. Cerenia should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.

Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.

Cerenia is not a sedative and some motion sick dogs may show nausea-like signs during travel such as salivation and lethargy. These signs are temporary and should resolve when the journey ends.

Incidents of pre-travel vomiting, usually within two hours post-dosing, were commonly reported (more than 1 but less than 10 animals in 100 animals treated) after administration of the 8 mg/kg dose.

User warnings

People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.

Wash hands after use. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Half-tablets should be stored for a maximum of two days after removal from the blister. Half-tablets should be returned to the opened blister and kept within the cardboard outer.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Keep out of the sight and reach of children.

For animal treatment only.

Legal category

Packaging quantities

Cerenia tablets are supplied in blister packs with four tablets per pack.

Further information

Nil.

Marketing Authorisation Number

EU/2/06/062/001-004

16mg » Pack of 4

Cerenia Tablets for dogs

Presentation

Each tablet contains 16 mg, 24 mg, 60 mg or 160 mg maropitant as maropitant citrate monohydrate. The tablets also contain Sunset Yellow (E110) as a colourant.

The tablets are pale orange and have a score line on both sides allowing the tablet to be halved. Each tablet is marked with the Pfizer logo on the reverse side. On the obverse side, each half is marked with the letters “MPT” and figures denoting the quantity of maropitant.

Uses

Cerenia tablets are indicated for the following:

Dosage and administration

For oral use in dogs.

For the prevention of nausea induced by chemotherapy and treatment and prevention of vomiting (except motion sickness) in dogs aged 8 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 2 mg maropitant per kg bodyweight, using the number of tablets given in the table below. Tablets are breakable along the score line on the tablet.

To prevent vomiting, tablets should be given more than 1 hour in advance. The duration of the effect is approximately 24 hours and, therefore, tablets can be given the night before administration of an agent that may cause emesis (e.g. chemotherapy).

Cerenia can be used as either tablets or Solution for Injection once daily. Cerenia Solution for Injection may be administered for up to five days and Cerenia Tablets for up to 14 days.

Cerenia tablets are effective in the treatment of vomiting, however in cases of frequent vomiting it is recommended to initiate treatment with Cerenia Solution for Injection.

* Correct dose for dogs of less than 3 kg cannot be accurately achieved.

For prevention of vomiting induced by motion sickness in dogs aged 16 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 8 mg maropitant per kg bodyweight, using the numbers of tablets given in the table below. Tablets are breakable along the score line on the tablet.

Tablets should be administered at least one hour before starting the journey. The anti-emetic effect persists for at least 12 hours, which for convenience may allow administration the night before early morning travel. Treatment may be repeated for a maximum of two consecutive days.

In some individual dogs and when repeating the treatment, lower doses than recommended might be sufficient.

To remove a tablet from the blister the following sequence should be carried out;

Note: No attempt should be made to remove the tablet by pushing it through the blister backing as this will damage both the tablet and blister.

A light meal or snack before dosing is recommended; prolonged fasting before administration should be avoided. Cerenia tablets should not be administered wrapped or encapsulated in food as this may delay dissolution of the tablet and consequently the onset of the effect.

Dogs should be carefully observed following administration to ensure that each tablet is swallowed.

Contra-indications, warnings, etc

Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.

Administering Cerenia on a completely empty stomach may cause the dog to vomit. A light snack before dosing could help prevent this effect.

The safety of Cerenia has not been established in dogs less than 16 weeks of age (for the 8 mg/kg dose: motion sickness) and in dogs less than 8 weeks of age (for the 2 mg/kg dose: vomiting), as well as in pregnant or lactating bitches. Use only according to a risk benefit assessment by the responsible veterinary surgeon.

Cerenia should be used in conjunction with other supportive measures if appropriate.

Cerenia tablets were well tolerated when administered for 15 days at dosages up to 10 mg/kg bodyweight per day. Clinical signs including vomiting on first administration, excess salivation and watery faeces have been observed when the product has been overdosed in excess of 20 mg/kg.

The safety of maropitant during treatment beyond 5 days has not been explored in young dogs with viral enteritis. In case treatment for a longer period than 5 days is required, careful monitoring of potential adverse events should be implemented.

Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease. As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function in addition to any adverse events should be implemented during long term treatment.

Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases. Cerenia should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.

Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.

Cerenia is not a sedative and some motion sick dogs may show nausea-like signs during travel such as salivation and lethargy. These signs are temporary and should resolve when the journey ends.

Incidents of pre-travel vomiting, usually within two hours post-dosing, were commonly reported (more than 1 but less than 10 animals in 100 animals treated) after administration of the 8 mg/kg dose.

User warnings

People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.

Wash hands after use. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Half-tablets should be stored for a maximum of two days after removal from the blister. Half-tablets should be returned to the opened blister and kept within the cardboard outer.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Keep out of the sight and reach of children.

For animal treatment only.

Legal category

Packaging quantities

Cerenia tablets are supplied in blister packs with four tablets per pack.

Further information

Nil.

Marketing Authorisation Number

EU/2/06/062/001-004

160mg » Pack of 4

Cerenia Tablets for dogs

Presentation

Each tablet contains 16 mg, 24 mg, 60 mg or 160 mg maropitant as maropitant citrate monohydrate. The tablets also contain Sunset Yellow (E110) as a colourant.

The tablets are pale orange and have a score line on both sides allowing the tablet to be halved. Each tablet is marked with the Pfizer logo on the reverse side. On the obverse side, each half is marked with the letters “MPT” and figures denoting the quantity of maropitant.

Uses

Cerenia tablets are indicated for the following:

Dosage and administration

For oral use in dogs.

For the prevention of nausea induced by chemotherapy and treatment and prevention of vomiting (except motion sickness) in dogs aged 8 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 2 mg maropitant per kg bodyweight, using the number of tablets given in the table below. Tablets are breakable along the score line on the tablet.

To prevent vomiting, tablets should be given more than 1 hour in advance. The duration of the effect is approximately 24 hours and, therefore, tablets can be given the night before administration of an agent that may cause emesis (e.g. chemotherapy).

Cerenia can be used as either tablets or Solution for Injection once daily. Cerenia Solution for Injection may be administered for up to five days and Cerenia Tablets for up to 14 days.

Cerenia tablets are effective in the treatment of vomiting, however in cases of frequent vomiting it is recommended to initiate treatment with Cerenia Solution for Injection.

* Correct dose for dogs of less than 3 kg cannot be accurately achieved.

For prevention of vomiting induced by motion sickness in dogs aged 16 weeks of age or older

Cerenia tablets should be administered once daily, at a dose of 8 mg maropitant per kg bodyweight, using the numbers of tablets given in the table below. Tablets are breakable along the score line on the tablet.

Tablets should be administered at least one hour before starting the journey. The anti-emetic effect persists for at least 12 hours, which for convenience may allow administration the night before early morning travel. Treatment may be repeated for a maximum of two consecutive days.

In some individual dogs and when repeating the treatment, lower doses than recommended might be sufficient.

To remove a tablet from the blister the following sequence should be carried out;

Note: No attempt should be made to remove the tablet by pushing it through the blister backing as this will damage both the tablet and blister.

A light meal or snack before dosing is recommended; prolonged fasting before administration should be avoided. Cerenia tablets should not be administered wrapped or encapsulated in food as this may delay dissolution of the tablet and consequently the onset of the effect.

Dogs should be carefully observed following administration to ensure that each tablet is swallowed.

Contra-indications, warnings, etc

Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed.

Administering Cerenia on a completely empty stomach may cause the dog to vomit. A light snack before dosing could help prevent this effect.

The safety of Cerenia has not been established in dogs less than 16 weeks of age (for the 8 mg/kg dose: motion sickness) and in dogs less than 8 weeks of age (for the 2 mg/kg dose: vomiting), as well as in pregnant or lactating bitches. Use only according to a risk benefit assessment by the responsible veterinary surgeon.

Cerenia should be used in conjunction with other supportive measures if appropriate.

Cerenia tablets were well tolerated when administered for 15 days at dosages up to 10 mg/kg bodyweight per day. Clinical signs including vomiting on first administration, excess salivation and watery faeces have been observed when the product has been overdosed in excess of 20 mg/kg.

The safety of maropitant during treatment beyond 5 days has not been explored in young dogs with viral enteritis. In case treatment for a longer period than 5 days is required, careful monitoring of potential adverse events should be implemented.

Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease. As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function in addition to any adverse events should be implemented during long term treatment.

Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases. Cerenia should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.

Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.

Cerenia is not a sedative and some motion sick dogs may show nausea-like signs during travel such as salivation and lethargy. These signs are temporary and should resolve when the journey ends.

Incidents of pre-travel vomiting, usually within two hours post-dosing, were commonly reported (more than 1 but less than 10 animals in 100 animals treated) after administration of the 8 mg/kg dose.

User warnings

People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.

Wash hands after use. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Half-tablets should be stored for a maximum of two days after removal from the blister. Half-tablets should be returned to the opened blister and kept within the cardboard outer.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Keep out of the sight and reach of children.

For animal treatment only.

Legal category

Packaging quantities

Cerenia tablets are supplied in blister packs with four tablets per pack.

Further information

Nil.

Marketing Authorisation Number

EU/2/06/062/001-004

20ml Solution » Bottle

Cerenia 10 mg/ml Solution for Injection for dogs and cats

Presentation

Cerenia solution for injection contains 10 mg maropitant per ml as maropitant citrate monohydrate as a clear, colourless to light yellow solution and metacresol as preservative.

Uses

Cerenia Solution for Injection is indicated for the following:

Dogs:

Cats:

Dosage and administration

For subcutaneous or intravenous use in dogs and cats.

Cerenia solution for injection should be injected subcutaneously or intravenously, once daily, at a dose of 1 mg/kg bodyweight (1 ml/10 kg bodyweight) for up to 5 consecutive days. Intravenous administration of Cerenia should be given as a single bolus without mixing the product with any other fluids.

In dogs, Cerenia can be used to treat or prevent vomiting either as tablets or as solution for injection administered once daily. Cerenia solution for injection may be administered for up to 5 days and Cerenia tablets for up to 14 days.

Although Cerenia is effective in the treatment and prevention of vomiting induced by chemotherapy, it is more efficacious if used preventatively. Therefore it is recommended to administer Cerenia prior to the administration of the chemotherapeutic agent.

To prevent vomiting, Cerenia solution for injection should be administered more than 1 hour in advance. The duration of effect is approximately 24 hours and therefore treatment can be given the night before administration of an agent that may cause emesis e.g. chemotherapy.

In some individual animals, and when repeating the treatment, lower doses than recommended might be sufficient.

Contra-indications, warnings, etc

Pain at injection site may occur when injected subcutaneously. In cats, moderate to severe response to injection is very commonly observed (approximately one third of cats).

In very rare cases, anaphylactic type reactions (allergic oedema, urticaria, erythema, collapse, dyspnoea, pale mucous membranes) may occur.

The frequency of adverse reactions is defined using the following convention:

Due to the frequent occurrence of transient pain during subcutaneous injection, appropriate animal restraining measures may be required. Injecting the product at refrigerated temperatures may reduce pain at injection.

Vomiting can be associated with serious, severely debilitating conditions including gastrointestinal obstructions; therefore, appropriate diagnostic evaluations should be employed. Cerenia solution for injection should be used with other supportive measures as appropriate.

The safety of Cerenia has not been established in dogs less than 8 weeks of age, in cats less than 16 weeks of age, and in pregnant or lactating dogs and cats. Use only according to a risk benefit assessment by the responsible veterinary surgeon.

Apart from transient reactions at the injection site following subcutaneous administration, Cerenia solution for injection was well tolerated in dogs and young cats injected daily with up to 5 mg/kg (5 times the recommended dose) for 15 consecutive days (3 times the recommended duration of administration). No data are available on overdoses in adult cats. Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases.

Cerenia should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels. Maropitant is metabolised in the liver and therefore should be used with caution in animals with liver disease. Cerenia should be used with caution in animals suffering from, or with, disposition for cardiac diseases as maropitant has affinity to Ca- and K-ion channels.

Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.

The use of Cerenia solution for injection against vomiting due to motion sickness is not recommended.

User warnings:

People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.

Wash hands after use. In case of accidental self-injection seek medical advice immediately and show the package leaflet or the label to the physician. In the case of accidental eye exposure, flush the eyes with plenty of water and seek medical attention.

Pharmaceutical precautions

This veterinary medicinal product does not require any special storage conditions.

Once opened, the vial should be used within 28 days.

In the absence of compatibility studies, Cerenia solution for injection must not be mixed with other veterinary medicinal products in the same syringe.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Keep out of the sight and reach of children.

For animal treatment only.

Legal category

Packaging quantities

Cerenia solution for injection is available in 20 ml amber glass vials.

Further information

The anti-emetic efficacy of maropitant against central and peripheral emetics was demonstrated in experimental studies.

Use only according to a benefit/risk assessment in pregnant and lactating animals as specific studies have not been performed.

Marketing Authorisation Number

EU/2/06/062/005

Delivery Information

How quickly do you deliver?

Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.

What do you charge for delivery?

For UK delivery, we charge the following:

Order Total Weight Delivery
£0-£28.99 Under 2kg £2.99
2kg+ £4.99
£29-£38.99 Under 2kg Free
2kg+ £4.99
£39+ Under 2kg Free
2kg+ Free

Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products, such as Insulin, are also not always subject to the standard and/or free delivery options.

For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.

We can deliver most items to all around the world, but prices do vary. The majority of light weight orders (less than 1.5kg) can be delivered for a flat rate of £10. For an accurate estimate of the delivery charge, please put the items you require in your basket and use the "Estimate Delivery" system on the shopping basket page (you only need to enter your country and postal/zip code) for a quick quote. For deliveries to the USA you may need to go to the checkout page and enter your full address to get a quote (as some services need your state in order to quote too). For more information on international deliveries, please see our delivery information page.

Delivery of aerosols

Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.

Delivery of temperature controlled items

Some products, such as insulin and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.

How do I cancel or return an order?

Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.

To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.

*For full details on returns, see our terms and conditions page.

Reviews (10)

Q & A

There are currently no questions for Cerenia - be the first to ask one!